Mary Tagliaferri's most recent trade in Y-Mabs Therapeutics Inc was a trade of 14,545 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on June 11, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Y-Mabs Therapeutics Inc | Mary A. Tagliaferri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 14,545 | 14,545 | - | - | Employee Stock Option (right to buy) | |
| Y-Mabs Therapeutics Inc | Mary A. Tagliaferri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 3,495 | 8,155 (0%) | 0% | 0 | Common Stock | |
| Y-Mabs Therapeutics Inc | Mary A. Tagliaferri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2024 | 27,900 | 27,900 | - | - | Stock Option (right to buy) | |
| Y-Mabs Therapeutics Inc | Mary A. Tagliaferri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2024 | 4,660 | 4,660 (0%) | 0% | 0 | Common Stock | |
| RayzeBio Inc. | Mary Tagliaferri | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 26 Feb 2024 | 73,731 | 0 | - | - | Employee Stock Option (right to buy) | |
| RayzeBio Inc. | Mary Tagliaferri | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 26 Feb 2024 | 40,848 | 0 | - | - | Employee Stock Option (right to buy) | |
| Enzo Biochem, Inc. | Tagliaferri Mary | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 79,365 | 312,383 (0%) | 0% | 0 | Common Stock | |
| Enzo Biochem, Inc. | Mary Tagliaferri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 75,188 | 155,917 (0%) | 0% | 0 | Common Stock, $0.01 Par Value | |
| Enzo Biochem, Inc. | Mary Tagliaferri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2022 | 41,666 | 80,729 (0%) | 0% | 0 | Common Stock, $0.01 Par Value | |
| Enzo Biochem, Inc. | Mary Tagliaferri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2022 | 39,063 | 39,063 (0%) | 0% | 0 | Common Stock, $0.01 Par Value | |
| Enzo Biochem, Inc. | Mary Tagliaferri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2021 | 77,101 | 77,101 | - | - | Stock Option (to acquire Common Stock) |